Yenerel, M. N. Et Al. 2014. The Importance of Eculizumab in Patients with Atypical Hemolytic Uremic Syndrome: Single Center Experience. BLOOD , vol.124, no.21 .

Yenerel, M. N., Aktan, M., Yildiz, A., Caliskan, Y., & Nalcaci, M., (2014). The Importance of Eculizumab in Patients with Atypical Hemolytic Uremic Syndrome: Single Center Experience. BLOOD , vol.124, no.21.

Yenerel, Mustafa Et Al. "The Importance of Eculizumab in Patients with Atypical Hemolytic Uremic Syndrome: Single Center Experience," BLOOD , vol.124, no.21, 2014

Yenerel, Mustafa N. Et Al. "The Importance of Eculizumab in Patients with Atypical Hemolytic Uremic Syndrome: Single Center Experience." BLOOD , vol.124, no.21, 2014

Yenerel, M. N. Et Al. (2014) . "The Importance of Eculizumab in Patients with Atypical Hemolytic Uremic Syndrome: Single Center Experience." BLOOD , vol.124, no.21.

@article{article, author={Mustafa Nuri YENEREL Et Al. }, title={The Importance of Eculizumab in Patients with Atypical Hemolytic Uremic Syndrome: Single Center Experience}, journal={BLOOD}, year=2014}